BUSINESS

Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits

CNBC BusinessTuesday, October 13, 2026 at 8:29 PM

RedScroll Brief

Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.

RedScroll Signal

Impact: High
Category: Business
Market relevance: High
Why it matters: Corporate and market moves reprice risk and reveal where power and cash are concentrating. Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization. Investors will watch earnings, rates, and competitive positioning connected to Walmart and Business.

Read original source → CNBC BUSINESS Edition 2026-10-13

Desk copy

RedScroll Briefing

Extractive editorial brief — not a reprint of the original

What happened

Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.

Why it matters

Corporate and market moves reprice risk and reveal where power and cash are concentrating.

Background

CNBC Business reported on this under business. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.

Timeline

Tue, Oct 13, 2026, 8:29 PM UTC
CNBC Business published: Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits
Now
Story is in today’s RedScroll edition. Follow the original source for updates.

Economic impact

Investors will watch earnings, rates, and competitive positioning connected to Walmart and Business.

Source

CNBC Business

Original reporting by CNBC Business. RedScroll provides an extractive briefing only.